本文關(guān)鍵詞：補(bǔ)益宗氣法針刺治療慢性阻塞性肺疾病穩(wěn)定期對患者肺功能的影響　出處：《福建中醫(yī)藥大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

  更多相關(guān)文章： 補(bǔ)益宗氣法 肺功能 COPD/慢性阻塞性肺疾病

【摘要】：目的:評價補(bǔ)益宗氣法針刺治療慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease,COPD)穩(wěn)定期患者對其肺功能的影響。方法:收集2016年到2017年在福建中醫(yī)藥大學(xué)附屬廈門市中醫(yī)院針灸科、呼吸科及推拿理療科門診接受治療的COPD穩(wěn)定期患者66例。根據(jù)隨機(jī)對照試驗的原則,將66例患者的分為兩組,對照組為33例,治療組為33例。對照組:采用西藥常規(guī)治療,予噻托溴銨粉霧劑吸入,qd,時間為2個月;治療組:采用升散方針刺治療,選取穴位為膻中、中脘、氣海、百會、偏歷、列缺,并根據(jù)兼癥配穴,隔日1次,一周3次,時間為2個月。對照組與治療組統(tǒng)計觀察時間均為2個月(即1療程),并于療程前后分別記錄患者的肺功能指標(biāo)、臨床癥狀體征情況、生活質(zhì)量情況,逐一進(jìn)行評估記錄,并選用統(tǒng)計軟件SPSS 20.0 for windows將所得到的數(shù)據(jù)進(jìn)行統(tǒng)計分析。結(jié)果:1、中醫(yī)證候及療效分析:①治療組經(jīng)升散方針刺治療后總有效率為86.67%,對照組采用西藥常規(guī)治療后總有效率為77.42%,兩組患者經(jīng)治療后有統(tǒng)計學(xué)差異(P0.05);②除自汗癥狀外(P0.05),治療組患者的肺部癥狀(包括咳嗽、咯痰、氣短、喘息、哮鳴)、納呆、腹脹、易感冒等癥狀較對照組均有明顯改善(P＜0.05);③治療組的中醫(yī)證候積分與其整體臨床癥狀較對照組顯著改善。2、肺功能分析:①兩組患者經(jīng)治療后,FEV1/FVC、FEV1/預(yù)計值%均有改善,具有統(tǒng)計學(xué)差異(P＜0.01);②兩組患者經(jīng)治療后,組間比較FEV1/預(yù)計值%具有統(tǒng)計學(xué)差異(P0.01),說明治療組對于肺功能通氣改善程度優(yōu)于對照組。3、生活質(zhì)量情況分析:①兩組患者經(jīng)治療后,與治療前相比CAT總分下降,患者心理、活動耐力、睡眠、社會影響等癥狀均減輕,具有統(tǒng)計學(xué)差異(P0.01);②兩組患者經(jīng)治療后,治療組患者CAT總分下降較對照組明顯,其療效優(yōu)于對照組,具有統(tǒng)計學(xué)差異(P＜0.01)。研究表明,補(bǔ)益宗氣法針刺治療COPD穩(wěn)定期患者可以延緩肺功能下降,減輕患者不適癥狀,促進(jìn)患者生活質(zhì)量的提升。結(jié)論:補(bǔ)益宗氣法針刺治療COPD穩(wěn)定期患者不僅能顯著緩解臨床癥狀、提高生活質(zhì)量,同時可改善FEV1/FVC、FEV1/預(yù)計值%,有效延緩肺功能下降,不失為一項卓有成效而安全的治療方法。
[Abstract]:Objective: to evaluate the treatment of chronic obstructive pulmonary disease (COPD) with Chronic Obstructive Pulmonary Disease. Methods: collected from 2016 to 2017 in the Department of Acupuncture and moxibustion of Xiamen City Hospital of Chinese Medicine affiliated to Fujian University of traditional Chinese Medicine. According to the principle of randomized controlled trial 66 patients were divided into two groups: 33 cases in control group. 33 cases in the treatment group. The control group was treated with routine western medicine and inhaled with tiotropium bromide powder for 2 months. The treatment group: the treatment group was treated with the principle of Shengsan Powder, selecting points as Tanzhong, Zhongwan, Qihai, Baihui, Dianli, and lack, and according to the syndromes of acupoints, once every other day, 3 times a week. The time was 2 months. The statistical observation time of the control group and the treatment group was 2 months (1 course of treatment). The pulmonary function indexes, clinical symptoms and signs, quality of life were recorded before and after the course of treatment. One by one, the statistical software SPSS 20.0 for windows was used to analyze the data. Results: 1. Analysis of TCM Syndrome and Therapeutic effect the total effective rate of the treatment group was 86.67 after being treated with Shengsan guideline, and the total effective rate of the control group was 77.42% after routine treatment with western medicine. After treatment, there was a significant difference between the two groups (P 0.05). 2 except for self-sweating symptoms, the pulmonary symptoms (including cough, sputum, shortness of breath, wheezing, dysphoria and abdominal distension) were found in the treatment group. Compared with the control group, the symptoms such as easy colds were significantly improved (P < 0.05). (3) the TCM syndrome score and its overall clinical symptoms in the treatment group were significantly improved compared with the control group. The pulmonary function analysis showed that the FEV1 / FVC+ FEV1 / predicted value% was improved after treatment in the two groups. There was statistical difference (P < 0.01). 2After treatment, there was statistical difference in FEV1 / predicted value% between the two groups, indicating that the improvement of pulmonary function in the treatment group was better than that in the control group (P < 0.05). Quality of life analysis: after treatment, compared with before treatment, the total score of CAT decreased, the patients' psychological, activity tolerance, sleep, social impact and other symptoms were alleviated. There was statistical difference (P 0.01). 2After treatment, the total score of CAT in the treatment group was significantly lower than that in the control group, and the curative effect was better than that in the control group (P < 0.01). Tonifying Zong Qi Acupuncture can delay the decline of pulmonary function and alleviate the uncomfortable symptoms of patients with COPD in stable period. Conclusion: acupuncture with tonifying Zong Qi method can not only relieve the clinical symptoms and improve the quality of life, but also improve the FEV1/FVC. FEV 1 / predicted value is an effective and safe treatment to delay the decline of lung function.
【學(xué)位授予單位】：福建中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R246.1

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;2016GOLD:COPD診斷、治療與預(yù)防全球策略(更新版)[J];中國全科醫(yī)學(xué);2016年05期

2 王玲玲;賈衛(wèi)華;楊杰;劉榮;馬艷東;;針刺加拔罐治療慢性阻塞性肺病穩(wěn)定期的療效觀察[J];針灸臨床雜志;2015年03期

3 高潔;張暮盈;;加味補(bǔ)中益氣湯緩解慢阻肺穩(wěn)定期呼吸肌疲勞的臨床觀察[J];現(xiàn)代中醫(yī)藥;2014年06期

4 肖建;杜春玲;;慢性阻塞性肺疾病病因及發(fā)病機(jī)制研究進(jìn)展[J];中國老年學(xué)雜志;2014年11期

5 朱銀興;蘭智慧;;淺談補(bǔ)益宗氣法治療慢性阻塞性肺疾病[J];江西中醫(yī)藥;2014年05期

6 官江;;參芪補(bǔ)肺湯對慢性阻塞性肺疾病穩(wěn)定期肺氣虛證患者肺功能的影響[J];大家健康(學(xué)術(shù)版);2014年07期

7 冉丕鑫;;慢性阻塞性肺疾病的危險因素與社區(qū)綜合防治[J];實用醫(yī)學(xué)雜志;2014年01期

8 郭泳梅;童娟;姚紅;;針刺療法對穩(wěn)定期慢性阻塞性肺疾病患者呼吸功能的影響[J];廣州中醫(yī)藥大學(xué)學(xué)報;2013年05期

9 王月蓉;施亞玲;王小燕;;玉屏風(fēng)散改善慢性阻塞性肺疾病穩(wěn)定期患者肺功能及生活質(zhì)量的臨床觀察[J];中國醫(yī)院用藥評價與分析;2012年09期

10 李佳倩;章璐;陳芳;徐艷艷;蔣玉宇;;慢性阻塞性肺疾病患者生活質(zhì)量評估研究近況[J];現(xiàn)代醫(yī)藥衛(wèi)生;2012年16期

相關(guān)博士學(xué)位論文 前1條

1 王麗華;洪廣祥運用宗氣理論治療慢性阻塞性肺疾病穩(wěn)定期的經(jīng)驗繼承與臨床研究[D];南京中醫(yī)藥大學(xué);2012年

，

本文編號：1415126